Identification and characterization of two chloramphenicol glucuronides from the in vitro glucuronidation of chloramphenicol in human liver microsomes

被引:17
|
作者
Chen, M.
Howe, D.
Leduc, B.
Kerr, S.
Williams, D. A.
机构
[1] CombinatoRx Inc, Dept Preclin Dev & Formulat, Cambridge, MA 02142 USA
[2] Massachusetts Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Boston, MA USA
[3] Vertex Pharmaceut Inc, Drug Innovat Pharmacokinet Dept, Cambridge, MA USA
关键词
chloramphenicol; human liver microsomes; glucuronidation; enzyme kinetics; chloramphenicol O-glucuronides; liquid chromatography coupled with tandem mass spectrometry detection (LC-MS/MS); DRUG-METABOLISM; TOXICITY; DISPOSITION; MODEL;
D O I
10.1080/00498250701620734
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study reports the development of a specific and sensitive liquid chromatography coupled with tandem mass spectrometry detection (LC-MS/MS) assay for the quantification of the in vitro O-glucuronidation of chloramphenicol (Cl?), the determination of the kinetic parameters for the O-glucuronidation of CP in pooled human liver microsomes (HLM), the biosynthesis of the CP glucuronides (CPGlu), and identification of the structures of CPGlu by H-1-nuclear magnetic resonance (NMR) and MS. Two glucuronyl derived metabolites of CP were obtained from the incubation of alamethicin-activated HLM with CP and uridine 5'-diphosphoglucuronic acid (UDPGA) in pH 7.4 TRIS buffer. Their identification and structural confirmation were achieved by beta-glucuronidase hydrolysis, in the presence and absence of UDPGA, and by H-1-NMR and LC-MS/ MS. These two metabolites were biosynthesized, isolated, and purified using high-performance liquid chromatography (HPLC). Their structures were further identified as the 1-O-CPGlu (the minor glucuronide formed at the secondary alcohol of CP) and 3-O-CPGlu (the major glucuronide formed at the primary alcohol of CP) by LC-MS/MS and two-dimensional NMR. The enzymatic kinetic parameters K-m and V-max in HLM for the 3-O-CPGlu were determined to be 650 mu M and 0.26 nmoles min(-1) mg(-1), respectively, and for the 1-O-CPGlu to be 301 mu M and 0.014 nmoles min(-1) mg(-1), respectively. This study also provides a sensitive and specific method for the measurement of in vitro CP-UDP-glucuronosyltransferase (UGT) activity.
引用
收藏
页码:954 / 971
页数:18
相关论文
共 50 条
  • [1] Glucuronidation of paracetamol by human liver microsomes in vitro
    Boldt, Petra
    Rothschild, Markus A.
    Kaeferstein, Herbert
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2007, 57 (12): : 787 - 794
  • [2] THE IDENTIFICATION AND CHARACTERIZATION OF CHLORAMPHENICOL-ALDEHYDE, A NEW HUMAN METABOLITE OF CHLORAMPHENICOL
    HOLT, DE
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1995, 20 (01) : 35 - 42
  • [3] In vitro glucuronidation of lamotrigine by human placental microsomes and human liver microsomes
    Argik, Upendra A.
    Remmel, Rory P.
    DRUG METABOLISM REVIEWS, 2006, 38 : 197 - 198
  • [4] Glucuronidation of aliphatic alcohols in human liver microsomes in vitro
    Jurowich, S
    Sticht, G
    Käferstein, H
    ALCOHOL, 2004, 32 (03) : 187 - 194
  • [5] Characterization of 1′-hydroxymidazolam glucuronidation in human liver microsomes
    Zhu, Bing
    Bush, David
    Doss, George A.
    Vincent, Stella
    Franklin, Ronald B.
    Xu, Shiyao
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (02) : 331 - 338
  • [6] Glucuronidation of mycophenolic acid (MPA) in vitro by human liver microsomes
    Desroches, M. C.
    Potin, S.
    Furlan, V.
    Taburet, A. M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 64 - 64
  • [7] IN VITRO ACTION OF CHLORAMPHENICOL AND CHLORAMPHENICOL ANALOGS ON HUMAN ERYTHROID TISSUE
    ERSLEV, AJ
    IOSSIFIDES, IA
    BLOOD, 1961, 18 (06) : 800 - &
  • [8] REDUCTIVE DECHLORINATION OF CHLORAMPHENICOL BY RAT-LIVER MICROSOMES
    MORRIS, PL
    BURKE, TR
    PHOL, LR
    DRUG METABOLISM AND DISPOSITION, 1983, 11 (02) : 126 - 130
  • [9] Characterization of In Vitro Glucuronidation Clearance of a Range of Drugs in Human Kidney Microsomes: Comparison with Liver and Intestinal Glucuronidation and Impact of Albumin
    Gill, Katherine L.
    Houston, J. Brian
    Galetin, Aleksandra
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (04) : 825 - 835
  • [10] Characterization of bropirimine O-glucuronidation in human liver microsomes
    Wynalda, MA
    Wynalda, KM
    Amore, BM
    Fagerness, PE
    Wienkers, LC
    XENOBIOTICA, 2003, 33 (10) : 999 - 1011